Interval invasive breast cancers diagnosed after a normal mammogram but before the next screening examination have a different tumour biology from that of screen-detected breast cancers, and thus are not detected on mammography. Understanding the genetics and biology of interval invasive cancers could inform better approaches to detection.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Houssami, N. & Hunter, K. The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening. NPJ Breast Cancer https://doi.org/10.1038/s41523-017-0014-x (2017).
Henderson, L. M. et al. Breast cancer characteristics associated with digital versus film-screen mammography for screen-detected and interval cancers. Am. J. Roentgenol. 205, 676–684 (2015).
Kerlikowske, K. et al. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann. Intern. Med. 162, 673–681 (2015).
Kirsh, V. A. et al. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program. J. Natl Cancer Inst. 103, 942–950 (2011).
Drukker, C. A. et al. Mammographic screening detects low-risk tumor biology breast cancers. Breast Cancer Res. Treatment 144, 103–111 (2014).
Mavaddat, N. et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am. J. Hum. Genet. 104, 21–34 (2019).
Vachon, C. M. et al. The contributions of breast density and common genetic variation to breast cancer risk. J. Natl Cancer Institute 107, https://doi.org/10.1093/jnci/dju397 (2015).
Li, J. et al. Differential burden of rare and common variants on tumor characteristics, survival, and mode of detection in breast cancer. Cancer Res. 78, 6329–6338 (2018).
Grassmann, F. et al. Interval breast cancer is associated with other types of tumors. Nat. Commun. 10, 4648 (2019).
Antoniou, A. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72, 1117–1130 (2003).
Goggins, W., Gao, W. & Tsao, H. Association between female breast cancer and cutaneous melanoma. Int. J. Cancer 111, 792–794 (2004).
Klein, A. P. Genetic susceptibility to pancreatic cancer. Mol. Carcinog. 51, 14–24 (2012).
Kerlikowske, K. et al. Strategies to identify women at high risk of advanced breast cancer during routine screening for discussion of supplemental imaging. JAMA Intern Med. 179 1230–1239 (2019).
Zhang, H. et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. bioRxiv. https://doi.org/10.1101/778605 (2019).
Bakker, M. F. et al. Supplemental MRI screening for women with extremely dense breast tissue. N. Engl. J. Med. 381, 2091–2102 (2019).
Acknowledgements
The authors received funding support from the National Cancer Institute (P01CA154292, K24CA169004 and K08CA237829).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Shieh, Y., Ziv, E. & Kerlikowske, K. Interval breast cancers — insights into a complex phenotype. Nat Rev Clin Oncol 17, 138–139 (2020). https://doi.org/10.1038/s41571-020-0327-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-020-0327-9